10.1016/j.isci.2020.101425
10.1016/j.isci.2020.101425 · doi-reference
10.2337/dc20-2257
10.2337/dc20-2257 · doi-reference
Bacteriophage cocktails in the post-COVID rehabilitation
10.3390/v14122614 · doi-reference
Phage Therapy in the Postantibiotic Era
10.1128/cmr.00066-18 · doi-reference
10.1016/j.humic.2019.100061
10.1016/j.humic.2019.100061 · doi-reference
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
10.1136/gutjnl-2018-316818 · doi-reference
A systematic review of probiotic interventions for gastrointestinal symptoms and irritable bowel syndrome in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)
10.1007/s12602-018-9397-8 · doi-reference
The emerging role of gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): current evidence and potential therapeutic applications
10.3390/jcm10215077 · doi-reference
Nutritional modulation of gut microbiota alleviates severe gastrointestinal symptoms in a patient with post-acute COVID-19 syndrome
10.1128/mbio.03801-21 · doi-reference
Dietary recommendations for Post-COVID-19 Ssyndrome
10.3390/nu14061305 · doi-reference
Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial
10.1080/19490976.2021.2018899 · doi-reference
10.1038/s41591-022-01909-w
10.1038/s41591-022-01909-w · doi-reference
The underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome
10.1016/j.yfrne.2022.100995 · doi-reference
10.1016/j.cmi.2021.11.002
10.1016/j.cmi.2021.11.002 · doi-reference
Could SARS-CoV-2 have bacteriophage behavior or induce the activity of other bacteriophages?
10.3390/vaccines10050708 · doi-reference
Gut microbiota dynamics in relation to long-COVID-19 syndrome: role of probiotics to combat psychiatric complications
10.3390/metabo12100912 · doi-reference
Molecular mechanisms of neuroinflammation in ME/CFS and long COVID to sustain disease and promote relapses
10.3389/fneur.2022.877772 · doi-reference
10.1038/s41586-020-2387-5
10.1038/s41586-020-2387-5 · doi-reference
The biological basis of chronic fatigue: neuroinflammation and innate immunity
10.1097/wco.0000000000000817 · doi-reference
The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: a hypothesis and review of literature
10.3389/fcimb.2022.983089 · doi-reference
10.1016/j.immuni.2017.05.011
10.1016/j.immuni.2017.05.011 · doi-reference
10.1126/science.abi6087
10.1126/science.abi6087 · doi-reference
Treatment of long-Haul COVID patients with off-label acyclovir
10.7759/cureus.37926 · doi-reference
10.1007/s00296-022-05146-9
10.1007/s00296-022-05146-9 · doi-reference
Could long COVID be linked to herpes viruses? Early data offer a hint
10.1038/d41586-022-02296-5 · doi-reference
10.1016/j.intimp.2021.108125
10.1016/j.intimp.2021.108125 · doi-reference
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
10.1007/s00134-022-06716-y · doi-reference
Confirmation of HIV-like sequences in respiratory tract bacteria of Cambodian and Kenyan HIV-positive pediatric patients
10.12659/msm.881449 · doi-reference
Persistence of Ebola virus in semen among Ebola virus disease survivors in Sierra Leone: a cohort study of frequency, duration, and risk factors
10.1371/journal.pmed.1003273 · doi-reference
Myalgic encephalomyelitis/chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity
10.3389/fped.2018.00373 · doi-reference
A multicenter virome analysis of blood, feces, and saliva in myalgic encephalomyelitis/chronic fatigue syndrome
10.1002/jmv.28993 · doi-reference
The gut microbiome in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS)
10.3389/fimmu.2021.628741 · doi-reference
Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England
10.1016/j.jinf.2021.12.047 · doi-reference
Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling
10.1172/jci.insight.164813 · doi-reference
Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID
10.1172/jci.insight.152346 · doi-reference
Potential implications of SARS-CoV-2 oral infection in the host microbiota
10.1080/20002297.2020.1853451 · doi-reference
The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort
10.1080/19490976.2021.1926840 · doi-reference
The role of enterovirus in chronic fatigue syndrome
10.1136/jcp.2004.020255 · doi-reference
A distinct microbiome signature in posttreatment lyme disease patients
10.1128/mbio.02310-20 · doi-reference
Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome
10.1186/s40168-017-0261-y · doi-reference
